Breaking News Instant updates and real-time market news.

AQUA

Evoqua Water

$32.80 /

+0.36 (+1.11%)

08:25
07/24/21
07/24
08:25
07/24/21
08:25

Evoqua stock a bet on clean water, Barron's says

Water is an economic paradox. Everyone needs it, but it's often cheap because it's usually, though not always, plentiful, Al Root writes in this week's edition of Barron's. Good water stocks, however, aren't plentiful-which makes Evoqua Water Technologies, a water-treatment company, a good stock to tap into, the author contends. Reference Link

  • 03

    Aug

  • 07

    Aug

  • 01

    Dec

  • 09

    Feb

AQUA Evoqua Water
$32.80 /

+0.36 (+1.11%)

07/07/21 Raymond James
Evoqua Water downgraded to Outperform from Strong Buy at Raymond James
07/07/21 Raymond James
Evoqua Water downgraded to Outperform from Strong Buy at Raymond James
06/23/21 Credit Suisse
Evoqua Water price target raised to $37 from $32 at Credit Suisse
06/16/21 RBC Capital
Evoqua Water price target raised to $38 from $34 at RBC Capital

TODAY'S FREE FLY STORIES

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/18/21
09/18
04:55
09/18/21
04:55
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, AYLA

Ayala Pharmaceuticals

$12.25 /

-0.01 (-0.08%)

, DCPH

Deciphera

$33.08 /

+1.45 (+4.58%)

, GMAB

Genmab

$43.10 /

+0.845 (+2.00%)

, LPTX

Leap Therapeutics

$2.65 /

+0.13 (+5.16%)

, ORIC

Oric Pharmaceuticals

$25.20 /

+0.99 (+4.09%)

, SYNH

Syneos Health

$94.34 /

+0.55 (+0.59%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, BYSI

BeyondSpring

$23.00 /

+0.47 (+2.09%)

, CALA

Calithera Biosciences

$2.25 /

+0.2 (+9.76%)

, GILD

Gilead

$71.61 /

+0.34 (+0.48%)

, GH

Guardant Health

$132.01 /

+5.01 (+3.94%)

, LLY

Eli Lilly

$230.17 /

-0.78 (-0.34%)

, IPSEY

Ipsen

$23.92 /

-0.395 (-1.62%)

, EXAS

Exact Sciences

$108.29 /

+5.47 (+5.32%)

, IDYA

Ideaya Biosciences

$26.90 /

+0.9 (+3.46%)

, GSK

GlaxoSmithKline

$38.94 /

-0.16 (-0.41%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, REGN

Regeneron

$651.38 /

-2.3 (-0.35%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, TAK

Takeda Pharmaceutical

$17.16 /

-0.045 (-0.26%)

, TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, VERU

Veru

$8.94 /

+0.17 (+1.94%)

, VBLT

VBL Therapeutics

$2.32 /

-0.035 (-1.49%)

, VTRS

Viatris

$13.57 /

-0.13 (-0.95%)

, NVS

Novartis

$83.49 /

-0.88 (-1.04%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$43.10 /

+0.845 (+2.00%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.61 /

+0.34 (+0.48%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$132.01 /

+5.01 (+3.94%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$651.38 /

-2.3 (-0.35%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
VERU Veru
$8.94 /

+0.17 (+1.94%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$83.49 /

-0.88 (-1.04%)

09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

Conference/Events
Truist to hold a virtual bus tour » 04:55
09/18/21
09/18
04:55
09/18/21
04:55
ATVI

Activision Blizzard

$79.61 /

+0.3 (+0.38%)

, EA

Electronic Arts

$133.92 /

-1.93 (-1.42%)

, MGNI

Magnite

$29.21 /

-0.275 (-0.93%)

, PLTK

Playtika

$26.92 /

-1.55 (-5.44%)

, RBLX

Roblox

$80.88 /

-0.62 (-0.76%)

, ROKU

Roku

$324.19 /

+0.96 (+0.30%)

, VZIO

Vizio

$19.09 /

+0.76 (+4.15%)

, ZNGA

Zynga

$8.00 /

+0.015 (+0.19%)

Digital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZNGA Zynga
$8.00 /

+0.015 (+0.19%)

VZIO Vizio
$19.09 /

+0.76 (+4.15%)

ROKU Roku
$324.19 /

+0.96 (+0.30%)

RBLX Roblox
$80.88 /

-0.62 (-0.76%)

PLTK Playtika
$26.92 /

-1.55 (-5.44%)

MGNI Magnite
$29.21 /

-0.275 (-0.93%)

EA Electronic Arts
$133.92 /

-1.93 (-1.42%)

ATVI Activision Blizzard
$79.61 /

+0.3 (+0.38%)

ATVI Activision Blizzard
$79.61 /

+0.3 (+0.38%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
EA Electronic Arts
$133.92 /

-1.93 (-1.42%)

09/15/21 Raymond James
Delay of EA's Battlefield 2042 likely a 'mild negative,' says Raymond James
MGNI Magnite
$29.21 /

-0.275 (-0.93%)

09/16/21 Susquehanna
Magnite upbeat analyst reaffirms positive thesis, says Susquehanna
08/31/21 Macquarie
Macquarie starts 'SSP leader' Magnite at Outperform
08/31/21 Macquarie
Magnite initiated with an Outperform at Macquarie
08/09/21 RBC Capital
Magnite assumed with an Outperform at RBC Capital
PLTK Playtika
$26.92 /

-1.55 (-5.44%)

09/10/21 Wedbush
Wedbush says Apple injunction could boost earnings for mobile game makers
09/10/21 Baird
Apple ruling could be positive for mobile game publishers, says Baird
08/05/21 Cowen
Playtika valuation remains extremely attractive, says Cowen
06/30/21 Morgan Stanley
Morgan Stanley double downgrades overvalued AppLovin to Underweight
RBLX Roblox
$80.88 /

-0.62 (-0.76%)

09/15/21 Benchmark
Benchmark reiterates Sell rating on Roblox after 'weak' August indicators
09/15/21 Truist
Roblox key performance indicators for August 'solid,' says Truist
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
08/31/21 Jefferies
China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
ROKU Roku
$324.19 /

+0.96 (+0.30%)

09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
09/09/21 Stephens
Premium prices of Amazon TVs reduces risk for Roku, says Stephens
09/09/21 KeyBanc
New Amazon Fire TVs 'incremental positive' for Roku, says KeyBanc
09/09/21 JPMorgan
Vizio added as new best idea in SMID-cap U.S. Internet at JPMorgan
VZIO Vizio
$19.09 /

+0.76 (+4.15%)

09/14/21
Fly Intel: Top five analyst initiations
09/14/21 Stephens
Stephens starts Vizio at Overweight with $27 price target
09/13/21 Stephens
Vizio initiated with an Overweight at Stephens
ZNGA Zynga
$8.00 /

+0.015 (+0.19%)

ZNGA Zynga
$8.00 /

+0.015 (+0.19%)

VZIO Vizio
$19.09 /

+0.76 (+4.15%)

ROKU Roku
$324.19 /

+0.96 (+0.30%)

RBLX Roblox
$80.88 /

-0.62 (-0.76%)

PLTK Playtika
$26.92 /

-1.55 (-5.44%)

MGNI Magnite
$29.21 /

-0.275 (-0.93%)

EA Electronic Arts
$133.92 /

-1.93 (-1.42%)

ATVI Activision Blizzard
$79.61 /

+0.3 (+0.38%)

  • 25
    Mar
  • 15
    Jan
ROKU Roku
$324.19 /

+0.96 (+0.30%)

RBLX Roblox
$80.88 /

-0.62 (-0.76%)

EA Electronic Arts
$133.92 /

-1.93 (-1.42%)

ATVI Activision Blizzard
$79.61 /

+0.3 (+0.38%)

ZNGA Zynga
$8.00 /

+0.015 (+0.19%)

VZIO Vizio
$19.09 /

+0.76 (+4.15%)

ROKU Roku
$324.19 /

+0.96 (+0.30%)

RBLX Roblox
$80.88 /

-0.62 (-0.76%)

PLTK Playtika
$26.92 /

-1.55 (-5.44%)

MGNI Magnite
$29.21 /

-0.275 (-0.93%)

EA Electronic Arts
$133.92 /

-1.93 (-1.42%)

ATVI Activision Blizzard
$79.61 /

+0.3 (+0.38%)

ZNGA Zynga
$8.00 /

+0.015 (+0.19%)

VZIO Vizio
$19.09 /

+0.76 (+4.15%)

ROKU Roku
$324.19 /

+0.96 (+0.30%)

RBLX Roblox
$80.88 /

-0.62 (-0.76%)

MGNI Magnite
$29.21 /

-0.275 (-0.93%)

EA Electronic Arts
$133.92 /

-1.93 (-1.42%)

ATVI Activision Blizzard
$79.61 /

+0.3 (+0.38%)

Periodicals
Pioneer Natural launches sale of assets in Delaware basin of Texas, Reuters says » 18:40
09/17/21
09/17
18:40
09/17/21
18:40
PXD

Pioneer Natural

$157.03 /

+0.04 (+0.03%)

Pioneer Natural Resources…

Pioneer Natural Resources has put its assets in the Delaware basin of Texas up for sale, looking to secure more than $2B for the properties, Reuters' Arathy Nair, David French, and Shariq Khan report, citing two sources familiar with the matter. Reference Link

ShowHide Related Items >><<
PXD Pioneer Natural
$157.03 /

+0.04 (+0.03%)

PXD Pioneer Natural
$157.03 /

+0.04 (+0.03%)

09/09/21
Fly Intel: Top five analyst upgrades
09/09/21 Goldman Sachs
Pioneer Natural upgraded to Conviction Buy from Buy at Goldman Sachs
07/22/21 Piper Sandler
Pioneer Natural price target raised to $218 from $216 at Piper Sandler
07/15/21 Mizuho
Pioneer Natural price target raised to $231 from $224 at Mizuho
PXD Pioneer Natural
$157.03 /

+0.04 (+0.03%)

  • 11
    May
PXD Pioneer Natural
$157.03 /

+0.04 (+0.03%)

PXD Pioneer Natural
$157.03 /

+0.04 (+0.03%)

PXD Pioneer Natural
$157.03 /

+0.04 (+0.03%)

Hot Stocks
Astellas Pharma, Pfizer: XTANDI improved OS in Phase 3 ARCHES study » 18:09
09/17/21
09/17
18:09
09/17/21
18:09
ALPMY

Astellas Pharma

$17.08 /

-0.14 (-0.81%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

Astellas Pharma (ALPMY)…

Astellas Pharma (ALPMY) and Pfizer (PFE) announced ahead of the European Society for Medical Oncology Congress 2021 that XTANDI improved overall survival in the ARCHES study in men with metastatic hormone-sensitive prostate cancer. The Phase 3, randomized, double-blind, placebo-controlled trial compared XTANDI plus androgen deprivation therapy versus placebo plus ADT in men with mHSPC and OS was a key secondary endpoint. In the study, XTANDI plus ADT reduced the risk of death by 34% compared to placebo plus ADT. Median OS, which represents the time from randomization to death due to any cause, was not reached in either treatment group. The safety profile in both study arms was consistent with findings from the primary analysis.

ShowHide Related Items >><<
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

ALPMY Astellas Pharma
$17.08 /

-0.14 (-0.81%)

ALPMY Astellas Pharma
$17.08 /

-0.14 (-0.81%)

06/29/21 Jefferies
Astellas Pharma downgraded to Hold from Buy at Jefferies
10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

Hot Stocks
Crocs director Bickley sells 5,000 common shares » 17:52
09/17/21
09/17
17:52
09/17/21
17:52
CROX

Crocs

$155.31 /

-2.39 (-1.52%)

In a regulatory filing,…

In a regulatory filing, Crocs director Ian Bickley disclosed the sale of 5,000 common shares of the company on September 16 at a price of $156.47 per share.

ShowHide Related Items >><<
CROX Crocs
$155.31 /

-2.39 (-1.52%)

CROX Crocs
$155.31 /

-2.39 (-1.52%)

09/15/21 Monness Crespi
Crocs price target raised to $180 from $160 at Monness Crespi
09/15/21 B. Riley
Crocs price target raised to $174 from $152 at B. Riley
09/15/21 Baird
Crocs price target raised to $215 from $160 at Baird
09/15/21 Loop Capital
Crocs price target raised to $180 from $150 at Loop Capital
CROX Crocs
$155.31 /

-2.39 (-1.52%)

CROX Crocs
$155.31 /

-2.39 (-1.52%)

CROX Crocs
$155.31 /

-2.39 (-1.52%)

CROX Crocs
$155.31 /

-2.39 (-1.52%)

Hot Stocks
NTSB to conduct safety investigation of fatal Tesla Model 3 crash in Florida » 17:48
09/17/21
09/17
17:48
09/17/21
17:48
TSLA

Tesla

$759.92 /

+2.995 (+0.40%)

The NTSB said that, in…

The NTSB said that, in coordination with City of Coral Gables Police Department, it is sending three investigators to conduct a safety investigation of the fatal Sept. 13, 2021, vehicle crash involving a Tesla Model 3 that departed the roadway and collided with a tree in Coral Gables, Florida. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$759.92 /

+2.995 (+0.40%)

TSLA Tesla
$759.92 /

+2.995 (+0.40%)

09/17/21 Morgan Stanley
520 mile EPA range 'an important milestone' for Lucid, says Morgan Stanley
09/17/21 Wedbush
Tesla EV demand story just starting to play out, says Wedbush
09/15/21 BofA
BofA calls Lucid the 'Tesla/Ferrari of new EV automakers,' starts at Buy
09/10/21 Craig-Hallum
VIA Optronics price target lowered to $14 from $18 at Craig-Hallum
TSLA Tesla
$759.92 /

+2.995 (+0.40%)

TSLA Tesla
$759.92 /

+2.995 (+0.40%)

TSLA Tesla
$759.92 /

+2.995 (+0.40%)

TSLA Tesla
$759.92 /

+2.995 (+0.40%)

Conference/Events
Angion Biomedica to host research and development virtual day » 17:38
09/17/21
09/17
17:38
09/17/21
17:38
ANGN

Angion Biomedica

$10.57 /

-0.38 (-3.47%)

Research and Development…

Research and Development Virtual Day to be held on September 20 at 10 am. Webcast Link

ShowHide Related Items >><<
ANGN Angion Biomedica
$10.57 /

-0.38 (-3.47%)

ANGN Angion Biomedica
$10.57 /

-0.38 (-3.47%)

03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Cowen
Angion Biomedica initiated with an Outperform at Cowen
03/02/21 Oppenheimer
Angion Biomedica initiated with an Outperform at Oppenheimer
03/02/21 Stifel
Angion Biomedica initiated with a Buy at Stifel
ANGN Angion Biomedica
$10.57 /

-0.38 (-3.47%)

  • 05
    Feb
ANGN Angion Biomedica
$10.57 /

-0.38 (-3.47%)

Hot Stocks
Azek exec Ochoa sells 20,000 class A shares » 17:37
09/17/21
09/17
17:37
09/17/21
17:37
AZEK

Azek

$38.56 /

+0.495 (+1.30%)

In a regulatory filing,…

In a regulatory filing, Azek Residential Segment President Joe Ochoa disclosed the sale of 20,000 class A common shares of the company on September 17 at a price of $38.67 per share.

ShowHide Related Items >><<
AZEK Azek
$38.56 /

+0.495 (+1.30%)

AZEK Azek
$38.56 /

+0.495 (+1.30%)

05/14/21 Baird
Azek price weakness a buying opportunity, says Baird
05/05/21 JPMorgan
Azek initiated with a Neutral at JPMorgan
04/13/21 Wedbush
Wedbush starts Azek with Outperform, $52 price target
04/12/21 Wedbush
Azek initiated with an Outperform at Wedbush
AZEK Azek
$38.56 /

+0.495 (+1.30%)

  • 27
    May
  • 22
    Jan
AZEK Azek
$38.56 /

+0.495 (+1.30%)

Syndicate
Greenidge Generation files to sell 3.5M shares of Class A common for holders  17:35
09/17/21
09/17
17:35
09/17/21
17:35
GREE

Greenidge Generation

$39.25 /

-4.35 (-9.98%)

 
Hot Stocks
Rolls-Royce awarded $194M Army contract » 17:17
09/17/21
09/17
17:17
09/17/21
17:17
RYCEY

Rolls-Royce

$1.49 /

+0.02 (+1.36%)

Rolls-Royce was awarded a…

Rolls-Royce was awarded a $194M firm-fixed-price contract for the acquisition of Namer Armored Personnel Carrier Power Packs Less Transmissions. Bids were solicited via the internet with one received. Work will be performed in Novi, Michigan, with an estimated completion date of December 31. FY20 Foreign Military Sales funds in the amount of $194M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.

ShowHide Related Items >><<
RYCEY Rolls-Royce
$1.49 /

+0.02 (+1.36%)

RYCEY Rolls-Royce
$1.49 /

+0.02 (+1.36%)

08/17/21 JPMorgan
Rolls-Royce price target raised to 130 GBp from 105 GBp at JPMorgan
08/09/21 Deutsche Bank
Rolls-Royce price target raised to 116 GBp from 113 GBp at Deutsche Bank
08/06/21 Societe Generale
Rolls-Royce price target raised to 100 GBp from 95 GBp at Societe Generale
07/09/21 Jefferies
Rolls-Royce coverage transferred at Jefferies
RYCEY Rolls-Royce
$1.49 /

+0.02 (+1.36%)

RYCEY Rolls-Royce
$1.49 /

+0.02 (+1.36%)

Hot Stocks
Abbott awarded $119.51M Defense Logistics Agency contract » 17:14
09/17/21
09/17
17:14
09/17/21
17:14
ABT

Abbott

$126.80 /

-0.65 (-0.51%)

Abbott was awarded a…

Abbott was awarded a maximum $119.51M indefinite-delivery/indefinite-quantity contract for over-the-counter antigen test kits. This was a competitive acquisition with three responses received. This is a one-year contract with no option periods. Location of performance is all 50 states, with a September 14, 2022, ordering period end date. Primary customer is the Department of Health and Human Services. Type of appropriation is FY21 through FY22 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support.

ShowHide Related Items >><<
ABT Abbott
$126.80 /

-0.65 (-0.51%)

ABT Abbott
$126.80 /

-0.65 (-0.51%)

09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
08/31/21 BTIG
Abbott price target raised to $136 from $126 at BTIG
08/31/21 Barclays
Abbott's Amulet could become 'needle mover,' says Barclays
08/30/21 Piper Sandler
Boston Scientific's Watchman still well positioned, says Piper Sandler
ABT Abbott
$126.80 /

-0.65 (-0.51%)

ABT Abbott
$126.80 /

-0.65 (-0.51%)

ABT Abbott
$126.80 /

-0.65 (-0.51%)

ABT Abbott
$126.80 /

-0.65 (-0.51%)

Hot Stocks
Quidel awarded $710.57M Defense Logistics Agency contract » 17:12
09/17/21
09/17
17:12
09/17/21
17:12
QDEL

Quidel

$153.43 /

+8.93 (+6.18%)

Quidel has been awarded a…

Quidel has been awarded a maximum $710.57M indefinite-delivery/indefinite-quantity contract for over-the-counter antigen test kits. This was a competitive acquisition with three responses received. This is a one-year contract with no option periods. Location of performance is all 50 states, with a September 14, 2022, ordering period end date. Primary customer is the Department of Health and Human Services. Type of appropriation is FY21 through FY22 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support.

ShowHide Related Items >><<
QDEL Quidel
$153.43 /

+8.93 (+6.18%)

QDEL Quidel
$153.43 /

+8.93 (+6.18%)

09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
07/26/21 Piper Sandler
Quidel agreement with Beckman removes overhang, says Piper Sandler
07/19/21 Raymond James
Quidel contract with Delaware could increase materially, says Raymond James
07/19/21 Raymond James
Quidel contact with Delaware could increase materially, says Raymond James
QDEL Quidel
$153.43 /

+8.93 (+6.18%)

QDEL Quidel
$153.43 /

+8.93 (+6.18%)

QDEL Quidel
$153.43 /

+8.93 (+6.18%)

Hot Stocks
Boeing awarded $1.62B Navy contract » 17:10
09/17/21
09/17
17:10
09/17/21
17:10
BA

Boeing

$213.37 /

+0.05 (+0.02%)

Boeing has been awarded a…

Boeing has been awarded a $1.62B indefinite-delivery/indefinite-quantity contract for missile guidance repair. This contract will repair the Minuteman III Intercontinental Ballistic Missile, or ICBM, missile guidance set. Work will be performed in Newark, Ohio, and is expected to be completed by September 27, 2039. This award is the result of a sole-source acquisition. FY21 operation and maintenance funds in the amount of $32.49M are being obligated at the time of award. The Air Force Nuclear Weapons Center is the contracting activity.

ShowHide Related Items >><<
BA Boeing
$213.37 /

+0.05 (+0.02%)

BA Boeing
$213.37 /

+0.05 (+0.02%)

09/15/21 Susquehanna
Boeing upcoming catalysts should move shares higher, says Susquehanna
09/07/21 UBS
Boeing price target lowered to $290 from $310 at UBS
09/07/21 Baird
Boeing delivery expectations may be too high, says Baird
09/01/21 Susquehanna
Boeing delivery estimates lowered due to continued suspension, says Susquehanna
BA Boeing
$213.37 /

+0.05 (+0.02%)

BA Boeing
$213.37 /

+0.05 (+0.02%)

BA Boeing
$213.37 /

+0.05 (+0.02%)

BA Boeing
$213.37 /

+0.05 (+0.02%)

Hot Stocks
Oscar Health CEO acquires 57,300 class A shares » 17:08
09/17/21
09/17
17:08
09/17/21
17:08
OSCR

Oscar Health

$17.50 /

+0.02 (+0.11%)

In a regulatory filing,…

In a regulatory filing, Oscar Health CEO Mario Schlosser disclosed the purchase of 57,300 class A common shares of the company on September 16 at a price of $17.5308 per share.

ShowHide Related Items >><<
OSCR Oscar Health
$17.50 /

+0.02 (+0.11%)

OSCR Oscar Health
$17.50 /

+0.02 (+0.11%)

09/09/21 Cowen
Oscar Health initiated with a Market Perform at Cowen
08/04/21 Morgan Stanley
Morgan Stanley upgrades Bright Health to Overweight following underperformance
03/29/21 Wells Fargo
Oscar Health initiated with an Overweight at Wells Fargo
03/29/21
Fly Intel: Top five analyst initiations
OSCR Oscar Health
$17.50 /

+0.02 (+0.11%)

  • 03
    Mar
OSCR Oscar Health
$17.50 /

+0.02 (+0.11%)

Syndicate
PBF Logistics files automatic mixed securities shelf  17:07
09/17/21
09/17
17:07
09/17/21
17:07
PBFX

PBF Logistics

$12.20 /

-0.17 (-1.37%)

 
ShowHide Related Items >><<
PBFX PBF Logistics
$12.20 /

-0.17 (-1.37%)

07/29/21 R.F. Lafferty
PBF Logistics price target lowered to $16 after earnings at R.F. Lafferty
02/17/21 Citi
PBF Logistics price target raised to $12 from $8.50 at Citi
PBFX PBF Logistics
$12.20 /

-0.17 (-1.37%)

Syndicate
Humacyte files to sell 90.07M shares of common stock for holders  17:02
09/17/21
09/17
17:02
09/17/21
17:02
HUMA

Humacyte

$14.25 /

+0.09 (+0.64%)

 
ShowHide Related Items >><<
HUMA Humacyte
$14.25 /

+0.09 (+0.64%)

HUMA Humacyte
$14.25 /

+0.09 (+0.64%)

09/16/21
Fly Intel: Top five analyst initiations
09/16/21 Piper Sandler
Humacyte initiated with an Overweight at Piper Sandler
04/09/21 Lake Street
Lake Street starts Alpha Healthcare Acquisition at Buy ahead of Humacyte closing
HUMA Humacyte
$14.25 /

+0.09 (+0.64%)

Syndicate
Alkaline Water files to sell 9.51M shares of common stock for holders  17:01
09/17/21
09/17
17:01
09/17/21
17:01
WTER

Alkaline Water

$1.63 /

+0.045 (+2.84%)

 
ShowHide Related Items >><<
WTER Alkaline Water
$1.63 /

+0.045 (+2.84%)

WTER Alkaline Water
$1.63 /

+0.045 (+2.84%)

07/07/21
Fly Intel: Top five analyst downgrades
07/07/21 Canaccord
Canaccord downgrades Alkaline Water to Sell, says rally overdone
07/06/21 Canaccord
Alkaline Water downgraded to Sell from Hold at Canaccord
WTER Alkaline Water
$1.63 /

+0.045 (+2.84%)

WTER Alkaline Water
$1.63 /

+0.045 (+2.84%)

Syndicate
ShiftPixy files to sell 15.42M shares of common stock for holders  16:50
09/17/21
09/17
16:50
09/17/21
16:50
PIXY

ShiftPixy

$1.24 /

-0.02 (-1.59%)

 
ShowHide Related Items >><<
PIXY ShiftPixy
$1.24 /

-0.02 (-1.59%)

PIXY ShiftPixy
$1.24 /

-0.02 (-1.59%)

Hot Stocks
Olympic Steel announces sale of Detroit assets for $58.4M » 16:44
09/17/21
09/17
16:44
09/17/21
16:44
ZEUS

Olympic Steel

$24.51 /

-0.35 (-1.41%)

Olympic Steel announced…

Olympic Steel announced the sale of substantially all of the company's Detroit assets and operations to Venture Steel. The sale price, which exceeded the book value of the net assets sold, was $58.4M in cash, subject to a future working capital adjustment, which is expected to increase the final sale price.

ShowHide Related Items >><<
ZEUS Olympic Steel
$24.51 /

-0.35 (-1.41%)

Syndicate
High Tide files $100M mixed securities shelf  16:41
09/17/21
09/17
16:41
09/17/21
16:41
HITI

High Tide

$6.81 /

+0.24 (+3.65%)

 
ShowHide Related Items >><<
HITI High Tide
$6.81 /

+0.24 (+3.65%)

HITI High Tide
$6.81 /

+0.24 (+3.65%)

09/13/21 Roth Capital
High Tide initiated with a Buy rating at Roth Capital
09/02/21 Desjardins
High Tide initiated with a Buy at Desjardins
HITI High Tide
$6.81 /

+0.24 (+3.65%)

Hot Stocks
FDA panel also recommends Pfizer booster for people with job exposure risk » 16:40
09/17/21
09/17
16:40
09/17/21
16:40
PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, BNTX

BioNTech

$358.75 /

-13.75 (-3.69%)

, MRNA

Moderna

$429.30 /

-11.54 (-2.62%)

According to CNBC's…

According to CNBC's Meg Tirrell, an FDA panel voted 18 "yes" to zero "no" to include healthcare workers or others at high risk for occupation exposure to be included in the Pfizer booster EUA. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
MRNA Moderna
$429.30 /

-11.54 (-2.62%)

08/06/21
Fly Intel: Top five analyst downgrades
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

On The Fly
Wall Street in Fives - Must Read Lists for Friday » 16:34
09/17/21
09/17
16:34
09/17/21
16:34
TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, FANG

Diamondback Energy

$82.56 /

+2.43 (+3.03%)

, X

U.S. Steel

$23.36 /

-2.03 (-8.00%)

, AMC

AMC Entertainment

$44.23 /

-1.82 (-3.95%)

, $ETH

Ethereum

/

+

, $BTC

Bitcoin

/

+

, BTC

Bitcoin

/

+

, BITCOIN

Bitcoin

/

+

, $LTC

Litecoin

/

+

, TTWO

Take-Two

$151.79 /

-0.1 (-0.07%)

, ACCD

Accolade

$45.35 /

+0.35 (+0.78%)

, LVS

Las Vegas Sands

$38.17 /

+0.66 (+1.76%)

, WYNN

Wynn Resorts

$83.30 /

-1.095 (-1.30%)

, FIVN

Five9

$175.22 /

+7.19 (+4.28%)

, ZM

Zoom Video

$287.58 /

+9.63 (+3.46%)

, IVZ

Invesco

$26.25 /

+1.37 (+5.51%)

, STT

State Street

$84.81 /

-2.195 (-2.52%)

, ZYME

Zymeworks

$35.62 /

-0.435 (-1.21%)

, UL

Unilever

$53.95 /

-0.585 (-1.07%)

, WFC

Wells Fargo

$46.46 /

+0.17 (+0.37%)

, DB

Deutsche Bank

$12.91 /

-0.21 (-1.60%)

, NOG

Northern Oil and Gas

$17.32 /

-1.12 (-6.07%)

, CRK

Comstock Resources

$8.66 /

-0.2 (-2.26%)

, IPHA

Innate Pharma

$8.07 /

+2.31 (+40.10%)

, AZN

AstraZeneca

$55.56 /

-1.04 (-1.84%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, PTGX

Protagonist Therapeutics

$17.60 /

-28.53 (-61.85%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, GRTS

Gritstone

$11.49 /

-2.015 (-14.93%)

, MANU

Manchester United

$18.00 /

+0.375 (+2.13%)

, CNI

Canadian National

$118.30 /

+2.45 (+2.11%)

, IFF

IFF

$135.21 /

-7.9 (-5.52%)

, PGR

Progressive

$92.64 /

-0.35 (-0.38%)

, MCFT

MasterCraft Boat

$25.60 /

+0.03 (+0.12%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, BNTX

BioNTech

$358.75 /

-13.75 (-3.69%)

Get caught up quickly on…

ShowHide Related Items >><<
ZYME Zymeworks
$35.62 /

-0.435 (-1.21%)

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

UL Unilever
$53.95 /

-0.585 (-1.07%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

STT State Street
$84.81 /

-2.195 (-2.52%)

PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NOG Northern Oil and Gas
$17.32 /

-1.12 (-6.07%)

MCFT MasterCraft Boat
$25.60 /

+0.03 (+0.12%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

IVZ Invesco
$26.25 /

+1.37 (+5.51%)

IPHA Innate Pharma
$8.07 /

+2.31 (+40.10%)

IFF IFF
$135.21 /

-7.9 (-5.52%)

GRTS Gritstone
$11.49 /

-2.015 (-14.93%)

FIVN Five9
$175.22 /

+7.19 (+4.28%)

FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

BITCOIN Bitcoin
/

+

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

ACCD Accolade
$45.35 /

+0.35 (+0.78%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

$BTC Bitcoin
/

+

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

09/15/21 Truist
Diamondback Energy price target raised to $130 from $122 at Truist
07/22/21 Piper Sandler
Diamondback Energy price target raised to $112 from $102 at Piper Sandler
07/15/21 Mizuho
Diamondback Energy price target raised to $131 from $120 at Mizuho
07/07/21 Wells Fargo
Diamondback Energy price target raised to $101 from $90 at Wells Fargo
X U.S. Steel
$23.36 /

-2.03 (-8.00%)

09/15/21 Deutsche Bank
U.S. Steel price target raised to $50 from $38 at Deutsche Bank
07/07/21 Credit Suisse
Steel demand booming in the U.S., says Credit Suisse
07/01/21 Deutsche Bank
U.S. Steel price target raised to $38 from $30 at Deutsche Bank
06/16/21
Fly Intel: Top five analyst downgrades
AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

09/01/21
Fly Intel: Top five analyst downgrades
09/01/21 Macquarie
AMC Entertainment downgraded to Underperform from Neutral at Macquarie
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
08/24/21 MKM Partners
Slow box office to make AMC Entertainment recovery difficult, says MKM Partners
$ETH Ethereum
/

+

05/07/21 Argus
Ethan Allen upgraded to Buy from Hold at Argus
05/07/21 Argus
Ethan Allen upgraded to Buy from Hold at Argus
11/24/20 UBS
RH price target raised to $450 from $380 at UBS
$BTC Bitcoin
/

+

09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
08/03/21 Craig-Hallum
Craig-Hallum bullish on Hut 8 Mining, initiates with a Buy
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

05/13/21 BTIG
BTIG sees Binance news as 'net positive' for Coinbase
$LTC Litecoin
/

+

06/03/21 Mizuho
LTC Properties downgraded to Underperform from Neutral at Mizuho
03/30/21 Capital One
LTC Properties downgraded to Equalweight from Overweight at Capital One
03/03/21 RBC Capital
LTC Properties price target raised to $38 from $33 at RBC Capital
02/09/21 Mizuho
LTC Properties price target raised to $38 from $35 at Mizuho
TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
ACCD Accolade
$45.35 /

+0.35 (+0.78%)

09/17/21
Fly Intel: Top five analyst upgrades
09/17/21 Baird
Baird upgrades Accolade to Outperform on execution, valuation discount
09/17/21 Baird
Accolade upgraded to Outperform from Neutral at Baird
07/13/21 Baird
Accolade price target raised to $58 from $54 at Baird
LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

09/17/21 Jefferies
Jefferies downgrades Las Vegas Sands on 'growth uncertainty' in Macau
09/17/21 Jefferies
Las Vegas Sands downgraded to Hold from Buy at Jefferies
09/16/21 JPMorgan
JPMorgan downgrades Las Vegas Sands on Macau uncertainty
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/16/21 JPMorgan
Wynn Resorts downgraded on Macau uncertainty at JPMorgan
FIVN Five9
$175.22 /

+7.19 (+4.28%)

09/17/21 Piper Sandler
Piper upgrades Five9 on potential for increased Zoom takeover bid
09/17/21 Piper Sandler
Five9 upgraded to Overweight from Neutral at Piper Sandler
09/09/21 JMP Securities
Nice price target raised to $343 from $302 at JMP Securities
09/07/21 Needham
Five9 upgraded to Buy from Hold at Needham
ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

09/03/21 UBS
DocuSign price target raised to $350 from $340 at UBS
IVZ Invesco
$26.25 /

+1.37 (+5.51%)

09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
07/12/21 Deutsche Bank
Invesco price target raised to $35 from $33 at Deutsche Bank
07/12/21 Citi
Invesco upgraded to Buy from Neutral at Citi
STT State Street
$84.81 /

-2.195 (-2.52%)

09/09/21 JPMorgan
JPMorgan expects 'sizable equity issue' from State Street after deal
09/08/21 Jefferies
State Street pullback on BBH deal a buying opportunity, says Jefferies
ZYME Zymeworks
$35.62 /

-0.435 (-1.21%)

09/13/21 Raymond James
Zymeworks data continue to outperform Herceptin, says Raymond James
08/05/21 H.C. Wainwright
Zymeworks price target lowered to $44 from $55 at H.C. Wainwright
03/30/21 Credit Suisse
Zymeworks initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Zymeworks initiated with an Outperform at Credit Suisse
UL Unilever
$53.95 /

-0.585 (-1.07%)

09/16/21 Deutsche Bank
Unilever downgraded to Hold from Buy at Deutsche Bank
09/02/21
Fly Intel: Top five analyst downgrades
09/02/21 JPMorgan
Unilever downgraded to Underweight from Neutral at JPMorgan
08/06/21 Morgan Stanley
Unilever upgraded to Equal Weight from Underweight at Morgan Stanley
WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

09/16/21 JPMorgan
JPMorgan does not expect Wells Fargo to be broken up
09/10/21 JPMorgan
Wells Fargo OCC fine 'moderate and manageable,' says JPMorgan
09/10/21 Morgan Stanley
Wells Fargo fine 'much lower' than Street baked in, says Morgan Stanley
09/01/21 Morgan Stanley
Morgan Stanley says Wells already warned investors more penalties could come
DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

09/17/21 JPMorgan
Deutsche Bank price target raised to EUR 13.50 from EUR 13 at JPMorgan
08/13/21
Fly Intel: Top five analyst upgrades
08/13/21 Keefe Bruyette
Deutsche Bank upgraded to Market Perform from Underperform at Keefe Bruyette
07/29/21 Credit Suisse
Deutsche Bank price target raised to EUR 10.50 from EUR 10 at Credit Suisse
NOG Northern Oil and Gas
$17.32 /

-1.12 (-6.07%)

09/01/21 Raymond James
Northern Oil and Gas price target raised to $32 at Raymond James
07/22/21 Piper Sandler
Northern Oil and Gas upgraded to Overweight from Neutral at Piper Sandler
07/01/21 Truist
Northern Oil and Gas price target raised to $33 from $25 at Truist
06/23/21 Piper Sandler
Northern Oil and Gas initiated with a Neutral at Piper Sandler
CRK Comstock Resources
$8.66 /

-0.2 (-2.26%)

07/15/21 Mizuho
Comstock Resources price target raised to $10 from $8 at Mizuho
07/13/21 Mizuho
Comstock Resources price target raised to $10 from $8 at Mizuho
04/20/21 Mizuho
Comstock Resources price target lowered to $8 from $9 at Mizuho
03/23/21 Citi
Comstock Resources price target lowered to $7 from $8 at Citi
IPHA Innate Pharma
$8.07 /

+2.31 (+40.10%)

09/17/21 Evercore ISI
Innate Pharma price target raised to $10 from $6 at Evercore ISI
09/02/21 SVB Leerink
SVB Leerink 'encouraged' by Innate's COAST update, upgrades to Outperform
09/02/21 SVB Leerink
Innate Pharma upgraded to Outperform from Market Perform at SVB Leerink
12/15/20
Fly Intel: Top five analyst downgrades
AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

09/17/21 Morgan Stanley
AstraZeneca price target raised to 10,000 GBp from 9,800 GBp at Morgan Stanley
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

09/17/21 Piper Sandler
Protagonist selloff 'overdone' following clinical hold, says Piper Sandler
09/17/21 Piper Sandler
Protagonist clinical hold brings more questions than answers, says Piper Sandler
08/06/21 H.C. Wainwright
Protagonist Therapeutics price target raised to $60 from $50 at H.C. Wainwright
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
GRTS Gritstone
$11.49 /

-2.015 (-14.93%)

01/21/21 BTIG
Gritstone Oncology price target raised to $35 from $17 at BTIG
01/20/21 H.C. Wainwright
Gritstone Oncology price target raised to $24 from $16 at H.C. Wainwright
01/20/21 Baird
Gritstone Oncology downgraded to Underperform from Outperform at Baird
MANU Manchester United
$18.00 /

+0.375 (+2.13%)

04/06/21 Deutsche Bank
Manchester United price target raised to $17 from $16 at Deutsche Bank
CNI Canadian National
$118.30 /

+2.45 (+2.11%)

09/17/21 RBC Capital
Canadian National reinstated at Outperform from Sector Perform at RBC Capital
09/16/21 National Bank
Canadian National price target raised to C$144 from C$139 at National Bank
09/15/21 Wolfe Research
Kansas City Southern downgraded to Peer Perform from Outperform at Wolfe Research
09/14/21 TD Securities
Canadian National downgraded to Hold from Buy at TD Securities
IFF IFF
$135.21 /

-7.9 (-5.52%)

07/20/21 Redburn
IFF initiated with a Buy at Redburn
06/28/21 Wells Fargo
IFF price target raised to $168 from $160 at Wells Fargo
05/13/21 Jefferies
IFF price target raised to $160 from $155 at Jefferies
05/12/21 Wells Fargo
IFF price target raised to $160 from $155 at Wells Fargo
PGR Progressive
$92.64 /

-0.35 (-0.38%)

08/17/21 Evercore ISI
Progressive added to 'Tactical Underperform List' at Evercore ISI
08/16/21 Wolfe Research
Progressive initiated with an Underperform at Wolfe Research
07/16/21 Barclays
Progressive price target lowered to $84 from $86 at Barclays
07/09/21 BofA
Progressive added to US 1 List; Arch Capital removed at BofA
MCFT MasterCraft Boat
$25.60 /

+0.03 (+0.12%)

09/02/21 Baird
MasterCraft Boat trading at 'absurd valuation,' says Baird
06/17/21 Truist
MasterCraft Boat price target lowered to $28 from $32 at Truist
05/13/21 Truist
MasterCraft Boat price target raised to $32 from $26 at Truist
05/13/21 B. Riley
MasterCraft Boat price target raised to $45 from $40 at B. Riley
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
ZYME Zymeworks
$35.62 /

-0.435 (-1.21%)

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

STT State Street
$84.81 /

-2.195 (-2.52%)

PTGX Protagonist Therapeutics
$17.60 /

-28.53 (-61.85%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NOG Northern Oil and Gas
$17.32 /

-1.12 (-6.07%)

MCFT MasterCraft Boat
$25.60 /

+0.03 (+0.12%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

IVZ Invesco
$26.25 /

+1.37 (+5.51%)

IFF IFF
$135.21 /

-7.9 (-5.52%)

GRTS Gritstone
$11.49 /

-2.015 (-14.93%)

FIVN Five9
$175.22 /

+7.19 (+4.28%)

FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CRK Comstock Resources
$8.66 /

-0.2 (-2.26%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

BITCOIN Bitcoin
/

+

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

ACCD Accolade
$45.35 /

+0.35 (+0.78%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

$BTC Bitcoin
/

+

  • 10
    Sep
  • 17
    Jun
  • 16
    Jun
  • 04
    Jun
  • 12
    Mar
  • 09
    Feb
  • 05
    Feb
  • 03
    Feb
  • 20
    Jan
  • 13
    Jan
  • 11
    Dec
  • 02
    Dec
  • 22
    Oct
ZYME Zymeworks
$35.62 /

-0.435 (-1.21%)

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

UL Unilever
$53.95 /

-0.585 (-1.07%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

STT State Street
$84.81 /

-2.195 (-2.52%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

NOG Northern Oil and Gas
$17.32 /

-1.12 (-6.07%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

IVZ Invesco
$26.25 /

+1.37 (+5.51%)

FIVN Five9
$175.22 /

+7.19 (+4.28%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

BITCOIN Bitcoin
/

+

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

$BTC Bitcoin
/

+

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

UL Unilever
$53.95 /

-0.585 (-1.07%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

FIVN Five9
$175.22 /

+7.19 (+4.28%)

FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CRK Comstock Resources
$8.66 /

-0.2 (-2.26%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

ACCD Accolade
$45.35 /

+0.35 (+0.78%)

$LTC Litecoin
/

+

$ETH Ethereum
/

+

ZM Zoom Video
$287.58 /

+9.63 (+3.46%)

X U.S. Steel
$23.36 /

-2.03 (-8.00%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WFC Wells Fargo
$46.46 /

+0.17 (+0.37%)

TTWO Take-Two
$151.79 /

-0.1 (-0.07%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

STT State Street
$84.81 /

-2.195 (-2.52%)

PGR Progressive
$92.64 /

-0.35 (-0.38%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MANU Manchester United
$18.00 /

+0.375 (+2.13%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

IVZ Invesco
$26.25 /

+1.37 (+5.51%)

FANG Diamondback Energy
$82.56 /

+2.43 (+3.03%)

DB Deutsche Bank
$12.91 /

-0.21 (-1.60%)

CNI Canadian National
$118.30 /

+2.45 (+2.11%)

AZN AstraZeneca
$55.56 /

-1.04 (-1.84%)

AMC AMC Entertainment
$44.23 /

-1.82 (-3.95%)

ACCD Accolade
$45.35 /

+0.35 (+0.78%)

$ETH Ethereum
/

+

Options
Preliminary option volume of 46.5M today » 16:30
09/17/21
09/17
16:30
09/17/21
16:30

Preliminary option volume…

Preliminary option volume of 46.5M today is 26% above recent average. Calls led puts 27.23M to 19.26M.

General news
Treasury Market Summary » 16:30
09/17/21
09/17
16:30
09/17/21
16:30
$ECON

Economic Data

/

+

Treasury Market Summary:…

Treasury Market Summary: Treasuries extended this week's losses with longer dated yields cheapening another couple of basis points and continuing to unwind the rally following Tuesday's tepid CPI data. Stronger than expected data and Fed angst has weighed on bonds as bulls have been sidelined. The 10-year has risen for 3 straight sessions to hit an intraday high of 1.384% before paring losses back to the 1.36% area. Wall Street ended a choppy week in the red with the S&P 500 and NASDAQ underperforming, falling -0.9% as rising rates weighed heavily on tech. The Dow was -0.48% lower. The uncertainties over the Fed, worries about tax hikes, covid and supply chain headwinds, and fears over China amid the regulatory crackdown/Evergrande problems have made for a very jittery investment environment. And the day's slippage saw the major indexes post declines for the week. Consumer sentiment was the only data, and it edged up a smaller than expected 0.7 ticks to 71.0.

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
FDA panel votes 18-0 for EUA for Pfizer booster for people 65+ » 16:27
09/17/21
09/17
16:27
09/17/21
16:27
PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, MRNA

Moderna

$429.30 /

-11.54 (-2.62%)

, BNTX

BioNTech

$358.75 /

-13.75 (-3.69%)

The panel said that known…

The panel said that known and potential benefits outweigh known and potential risks of the Pfizer vaccine booster at least six months out for us in adutls 65 and older and those at high risk of severe COVID-19.

ShowHide Related Items >><<
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
MRNA Moderna
$429.30 /

-11.54 (-2.62%)

08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/06/21
Fly Intel: Top five analyst downgrades
BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

BNTX BioNTech
$358.75 /

-13.75 (-3.69%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

MRNA Moderna
$429.30 /

-11.54 (-2.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.